欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号AT/H/0629/001
药品名称Terlipressin EVER Pharma 0.2 mg/ml Solution for injection
活性成分
    • terlipressin 0.2 mg/ml
剂型Solution for injection/infusion
上市许可持有人EVER Valinject Oberburgau 3 A-4866 Unterach
参考成员国 - 产品名称Austria (AT)
Terlipressinacetat EVER Pharma 0,2 mg/ml Injektionslösung
互认成员国 - 产品名称
    • Germany (DE)
      Terlipressin EVER Pharma 0,2mg/ml Injektionslösung
    • United Kingdom (Northern Ireland) (XI)
    • France (FR)
    • Spain (ES)
    • Italy (IT)
    • Poland (PL)
      Terlipressini acetas Ever Pharma
    • Czechia (CZ)
      Terlipresin acetát EVER Pharma
    • Romania (RO)
    • Slovakia (SK)
      Terlipresín EVER Pharma 0,2 mg/ml injekčný roztok
    • Bulgaria (BG)
      Terlipressin acetate EVER Pharma
    • Ireland (IE)
    • Portugal (PT)
许可日期2016/09/22
最近更新日期2024/05/31
药物ATC编码
    • H01BA04 terlipressin
申请类型
  • TypeLevel1：Known Active Substance
  • TypeLevel2：Initial Application
  • TypeLevel3：Other Generic application Art 10.3 Dir 2001/83/EC
  • TypeLevel4：Chemical Substance
  • TypeLevel5：Prescription Only
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase